Exhibit 99.1 Conference Call Today at 4:30 p.m. ET SAN DIEGO, February 12, 2026 -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2025, and provided an update on recent developments. Key Highlights Clinical and Corporate Update Clinical Progress in Cancer Trial Enrollment and treatment of partic ...